Q beyond : Presentation "Strategy 2025"
Strategy 2025 Virtual Analyst and Investor Conference 30 March 2023 Disclaimer This presentation contains... | March 30, 2023
Source: marketscreener.com
📰 Arch News
Page 786 - Arch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arch. Real-time updates on events, politics, business and more.
Sumitomo Forestry : Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2023
March 30, 2023 For Immediate Release Company name: Sumitomo Forestry Co., Ltd. Representative:... | March 30, 2023
Toshihiro Horii Toshiro Mitsuyoshi Tokyo Stock Exchange Company On Corporate Communications Dept Sumitomo Forestry Co Ltd
Source: marketscreener.com
Diffusion Pharmaceuticals : FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT - Form 8-K
FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT This Parent Stockholder Support Agreement, dated as of March 30, 2023 , by and between EIP Pharma, Inc., a Delaware corporation ,... | March 30, 2023
Source: marketscreener.com
Waberer International : Analyst conference call transcript
FOURTH QUARTER 2022 RESULTS ANALYST CONFERENCE CALL TRANSCRIPT 29 MARCH 2023, 14:00 CET [Presentation slides available here] ... | March 30, 2023
Source: marketscreener.com
EDP Renováveis S A : EDPR informs about agreement with First Solar to secure solar modules
Madrid, March 30th 2023: EDP Renováveis, S.A. announces an agreement with First Solar, Inc. , the largest PV solar panel manufacturer in the Western Hemisphere with a fully... | March 30, 2023
Source: marketscreener.com
Orascom Development : ERGEBNISSE PRÄSENTATIONFY 2022
Altdorf, March 30th, 2023 FY 2022 Results Analyst & Investor Presentation Table of Contents ... | March 30, 2023
Operational Highlights Orascom Development Holding Ag Stock Exchange Press Release F Odhn Ch0038285679
Source: marketscreener.com
Vigil Neuroscience Announces FDA Has Lifted the Partial Clinical Hold on VGL101
Company remains on track to report interim data from Phase 2 trial in the second half of 2023WATERTOWN, Mass., March 30, 2023 -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology... | March 30, 2023
United States Ivana Magov Drug Administration Vigil Neuroscience Inc Chief Executive Officer Fast Track
Source: marketscreener.com
ASLAN Pharmaceuticals : Company Presentation March 2023
Company presentation March 2023 NASDAQ: ASLN Legal disclaimer This... | March 30, 2023
Pharmaceuticals Limited The Company Decision Resources Group Company Form Drug Administration Commission File No Exchange Commission
Source: marketscreener.com
Argo Gold : Lindbergh Oil Well on Production
Oil Tanks at the Lindbergh Area - Sparky Oil Project Toronto, CANADA, March 30, 2023. Argo Gold Inc. announces that the Lindbergh Area Sparky oil well was drilled in mid-March 2023 and... | March 30, 2023
Source: marketscreener.com
AXCELLA HEALTH INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
Item 2.02. Results of Operations and Financial Condition. On March 30, 2023, Axcella Health Inc., doing business as Axcella Therapeutics, announced its financial results for the fourth quarter and... | March 30, 2023
Securities Exchange Description Press Axcella Health Inc Health Inc Current Report Securities Exchange Act
Source: marketscreener.com